Dihexa is a small peptidomimetic compound derived from angiotensin IV, studied for its activity as a potent agonist of the HGF/c-Met signaling system — a pathway researchers have linked to dendritic spine formation and synaptic connectivity in neural tissue models. Published research has examined Dihexa's role in activating hepatocyte growth factor (HGF) signaling, which researchers have associated with new synapse formation and plasticity in hippocampal tissue models. Studies have documented its effects on dendritic spine density and hippocampal connectivity in preclinical research settings. The c-Met/HGF pathway has attracted significant research interest in the context of neural plasticity and synaptic architecture. Dihexa's documented activity in this pathway has made it a subject of investigation for researchers examining neuroplasticity mechanisms, memory function research, and neurodegenerative disease models. Available in tablet form for research use. For research use only.

Dihexa is a peptidomimetic compound studied for its role in HGF/c-Met pathway activation and dendritic spine formation in synaptic connectivity research models. Published research examines its effects on hippocampal synaptic density in preclinical settings. 99% purity, batch-verified. For research use only. Available as Tablets. Sold in 20 mg tablets units. Every batch is independently third-party tested: HPLC purity confirmed at ≥99%, with mass spectrometry identity verification. A batch-specific Certificate of Analysis (COA) ships with every order. US-based supplier with same-day dispatch on orders before the daily cutoff (HST). For research use only. Not for human consumption.